Table 2.
Univariate | Multivariate | |||
---|---|---|---|---|
Parameter (Unfavorable vs. Favorable) |
HR (95% CI) |
p-Value |
HR (95% CI) |
p-Value |
Pathological T-factor | 2.68 | 0.168 | ||
(T3,4 vs. T1,2) | (0.85–16.30) | |||
Pathological N-factor | 2.69 | 0.0010 | 3.24 | 0.0012 |
(Positive vs. Negative) | (1.44–5.57) | (1.54–7.79) | ||
Lymphatic permeation | 2.43 | 0.0106 | 1.029 | 0.948 |
(Positive vs. Negative) | (1.21–5.81) | (0.409–2.23) | ||
Residual tumor | 1.96 | 0.0147 | 1.69 | 0.0724 |
(R1 > R0) | (1.15–3.18) | (0.95–2.87) | ||
Completed adjuvant chemotherapy | 2.54 | <0.0001 | 2.88 | <0.0001 |
(No > Yes) | (1.62–4.07) | (1.81–4.66) | ||
Resectability | 1.12 | 0.622 | ||
(BR + UR vs. R) | (0.693–1.761) |
HR: Hazard ratio, R: resectable, BR: borderline resectable, UR: unresectable.